Marjolein L Smidt (M L Smidt, Marjolein Smidt)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Top Venues

BMC microbiology

Breast cancer research : BCR

International journal of colorectal disease

European journal of cancer care

This page only lists publications with an associated author ORCID identifier.

Publications

Janine Ziemons, Lars E Hillege, Romy Aarnoutse, Judith De Vos-Geelen, Liselot Valkenburg-van Iersel, Jasper Mastenbroek, Robin M J M van Geel, David J M Barnett, Sander S Rensen, Ardy van Helvoort, Lotte H J Dopheide, Guus Roeselers, John Penders, Marjolein L Smidt, Koen Venema
Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon. BMC microbiology 24 (1) (2024)
Janine Ziemons, Lars E Hillege, Romy Aarnoutse, Judith De Vos-Geelen, Liselot Valkenburg-van Iersel, Jasper Mastenbroek, Robin M J M van Geel, David J M Barnett, Sander S Rensen, Ardy van Helvoort, Lotte H J Dopheide, Guus Roeselers, John Penders, Marjolein L Smidt, Koen Venema
Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon. BMC microbiology 24 (1) (2024)
Van Bockstal Mieke, Jelle Wesseling, Esther H Lips, Marjolein L Smidt, Christine Galant, Carolien H M van Deurzen
Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance. Breast cancer research : BCR 26 (1) (2024)
Janine Ziemons, Lars E Hillege, Romy Aarnoutse, Judith De Vos-Geelen, Liselot Valkenburg-van Iersel, Jasper Mastenbroek, Robin M J M van Geel, David J M Barnett, Sander S Rensen, Ardy van Helvoort, Lotte H J Dopheide, Guus Roeselers, John Penders, Marjolein L Smidt, Koen Venema
Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon. BMC microbiology 24 (1) (2024)
Van Bockstal Mieke, Jelle Wesseling, Esther H Lips, Marjolein L Smidt, Christine Galant, Carolien H M van Deurzen
Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance. Breast cancer research : BCR 26 (1) (2024)
Lori M van Roozendaal, Marissa L G Vane, E Colier, Luc J A Strobbe, M de Boer, Gabe S Sonke, Marissa C Van Maaren, Marjolein L Smidt
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed. Breast cancer research and treatment (2023)
Janine Ziemons, Romy Aarnoutse, Anne Heuft, Lars E Hillege, Janneke Waelen, Judith De Vos-Geelen, Liselot Valkenburg-van Iersel, Irene E G van Hellemond, Geert-Jan M Creemers, Arnold Baars, Johanna H M J Vestjens, John Penders, Koen Venema, Marjolein L Smidt
Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer. Clinical and experimental medicine (2023)
Wilma Savelberg, Liesbeth J Boersma, Marjolein L Smidt, Trudy van der Weijden
Implementing a breast cancer patient decision aid: Process evaluation using medical files and the patients' perspective. European journal of cancer care 30 (4) (2020)
R Aarnoutse, J M P G M de Vos-Geelen, J Penders, E G Boerma, F A R M Warmerdam, B Goorts, S W M Olde Damink, Z Soons, S S M Rensen, Marjolein L Smidt
Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0. International journal of colorectal disease 32 (7) (2017)